Amlodipine News
Cadila Healthcare receives 3 New Product Approvals USFDA
Cadila Healthcare Ltd has announced that the Company has received three product approvals from the USFDA in quick succession. The group has received approvals to market Benzonatate Tablets 100 and 200 mg, Naproxen Tablets and...
Amlodipine and Olmesartan Study Results Released; Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
Combining the calcium channel blocker amlodipine besylate with the angiotensin receptor blocker olmesartan medoxomil, produced significant mean reductions in seated systolic and diastolic blood pressure in patients with...
U.S. District Court Enjoins the FDA from Approving Additional Amlodipine Besylate ANDAs
Mylan Laboratories Inc. was notified yesterday that the U.S. District Court for the District of Columbia has enjoined the U.S. Food and Drug Administration (FDA) from approving any additional Abbreviated New Drug Applications...
Pfizer Wins Challenge to Norvasc Patent by Mylan
Pfizer Inc said today that a federal court in the Western District of Pennsylvania (Pittsburgh) has upheld the company's U.S. patent covering the active ingredient in Norvasc, the world's most-prescribed branded medicine for...
Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients
The aim of this study was to assess the effect of valsartan addition to amlodipine on ankle foot volume (AFV) and pretibial subcutaneous tissue pressure (PSTP), two objective measures of ankle oedema.